All Stories

  1. Resting-state electroencephalography microstates in antipsychotic-naïve individuals across the psychosis spectrum
  2. Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
  3. Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  4. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: the Neuro-VR study
  5. Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  6. Cognitive profiles across the psychosis continuum
  7. Publisher Correction: Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  8. Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  9. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
  10. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
  11. Brief rapport: Perceptual aberration in patients at ultra‐high risk for psychosis
  12. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
  13. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia
  14. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis
  15. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis
  16. Premorbid functioning in adolescence associates with comorbid disorders in individuals at ultra‐high risk for psychosis: A brief report
  17. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis
  18. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
  19. Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
  20. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
  21. Cortico-cognition Coupling in Treatment Resistant Schizophrenia
  22. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
  23. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis
  24. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra‐high risk for psychosis
  25. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
  26. Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis
  27. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
  28. Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
  29. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
  30. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
  31. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
  32. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
  33. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends
  34. Predictors of remission from the ultra‐high risk state for psychosis
  35. Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC)
  36. Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis
  37. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
  38. Development of Executive Functions as Reflected in Daily Life Behaviors in Young Adults at Ultra-High Risk for Psychosis: Associations With Symptoms and Functioning
  39. Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis
  40. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
  41. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
  42. Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies
  43. T16. GLUTAMATERGIC CHANGES IN UHR
  44. Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
  45. The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
  46. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
  47. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?